News
Vektor Medical doses first patients in IMPRoVED-AF study using vMap to guide effective atrial fibrillation ablation: San Diego Friday, July 11, 2025, 15:00 Hrs [IST] San Diego-hea ...
Vektor Medical, a medical technology company transforming standard ECG data into actionable insights that guide arrhythmia ...
On the heels of the first pulsed-field ablation device to win approval for atrial fibrillation ablation, a novel version of ...
Introduction: Currently, the treatment of atrial fibrillation (AF) focuses on restoring sinus rhythm with pulmonary vein isolation (PVI). Pulsed-field ablation (PFA) is a novel, promising method that ...
A new combination of inputs for the estimation of left ventricular filling pressure has shown to outperform those from ...
Four complex heart surgeries were done without a single chest cut using TPVR Read ahead to know how this minimally invasive ...
The study led by researchers from the Vardhman Medical College & Safdarjung Hospital, New Delhi, showed that diabetes is a ...
Diabetes may not only lead to joint pain that can severely damage your knee but also increase the risk of infections and ...
Patients whose atrial fibrillation lasts longer than seven days and who do not respond well to drug therapy are now eligible ...
There is increased risk for pulmonary hypertension in patients with both atrial fibrillation and incident venous thromboembolism.
New findings link postpartum haemorrhage (PPH) to long-term heart risks, prompting experts to urge lifelong maternal care and routine cardiovascular screening for affected women.
Targeted ablation guided by voltage mapping improved rhythm outcomes in individuals with recurrent atrial fibrillation after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results